Symposium Will Honor Helen Hobbs and Jonathan Cohen for Pioneering Work on Dyslipidemias and Metabolic Liver Disease; In-Person & Virtual Attendance Offered for May 31 Special Event

Helen Hobbs, MD

The 2023 Ross Prize Symposium “Genetic Basis of Lipid Metabolism Disorders” will take place on Wednesday, May 31, 2023, honoring Helen Hobbs, MD, and Jonathan Cohen, PhD, of the University of Texas Southwestern Medical Center (UTSWMC). Dr. Hobbs and Dr. Cohen are being recognized for their pioneering and collaborative work in defining the genetic risk factors for dyslipidemias and metabolic liver disease, which led to the rational design of new therapies to treat these diseases. This special annual event is jointly presented by the New York Academy of Sciences, the Feinstein Institute for Medical Research, and the journal Molecular Medicine. Dr. Hobbs and Dr. Cohen are the tenth winners of this illustrious award. They join the ranks of other renowned scientists known for their groundbreaking work, including Adrian Krainer, MD; Dan Kastner, MD, PhD; Huda Zoghbi, MD; Jeffrey Ravetch, MD, PhD; Charles Serhan, PhD, DSc; Lewis Cantley, MD; John O'Shea, MD; Dan Littman, MD, PhD;  Kaitlin Karikó, PhD; and Drew Weissman, MD, PhD.

Login Or Register To Read Full Story